Cite
HARVARD Citation
Abbas, S. et al. (n.d.). Risk of hyperkalemia and combined use of spironolactone and long‐term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real‐life data: a population‐ and insurance‐based cohort†. Pharmacoepidemiology and drug safety. pp. 406-413. [Online].